Malaysian Genomics Resource Centre Berhad is a leading genomics and biopharmaceutical company serving Southeast Asia from its new headquarters and central laboratory in Selangor, Malaysia. The Company was established in 2004 and listed on the Bursa Malaysia stock exchange in 2010. From pioneering work in genome sequencing, bioinformatics analysis, and genetic screening services, Malaysian Genomics has expanded into the biopharmaceutical sector with immunotherapy for various types of cancer